Histrine Levo 5mg tablets
Ferron Par Pharmaceuticals
Ingredients in every tablet
| Levocetirizine dihydrochloride | 5 mg |
Each package contains
3 strips of 10 tablets
Dosage form
 |
tablet |
Dosage formTablet; coated
Flavour
None
W.H.O. classification
R06A
R06A
A.T.C. Level 1
Anatomical Main group
R - Respiratory system
R06A
A.T.C. Level 2
Therapeutic subgroup
R06 - Antihistamines for Systemic Use
R06A
A.T.C. Level 3
Pharmacological subgroup
R06A - Antihistamines for Systemic Use
Available in
Warnings
Alcohol
CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
NOT RECOMMENDEDThis item should not be used while operating heavy machinery.
Pregnancy
NOT RECOMMENDEDThis item is not safe for use during pregnancy.
Lactation
NOT RECOMMENDEDThis item is not safe for use during lactation.
Indication
Levocetirizine is indicated for the treatment of symptoms associated with allergic conditions, such as:
Seasonal Allergic Rhinitis (including ocular symptoms)
Perennial Allergic Rhinitis
Chronic Idiopathic Urticaria
Seasonal Allergic Rhinitis (including ocular symptoms)
Perennial Allergic Rhinitis
Chronic Idiopathic Urticaria
Dosage
6 YEARS OLD AND ABOVE
The daily recommended dose is 5 mg (1 tablet)
UP TO 6 YEARS
No adjusted dosage is yet possible.
ELDERLY PATIENTS
Adjustment of the dose is recommended in elderly patients with moderate to severe renal impairment.
DURATION OF USE
The duration of use depends on the type, duration and course of the complaints. For hay fever 3-6 weeks, and in case of short-term pollen exposure as little as one week, is generally sufficient. For chronic urticaria and chronic allergic rhinitis, up to one year’s clinical experience is available for the racemate and up to 18 months in patients with pruritus associated with atopic dermatitis.
The daily recommended dose is 5 mg (1 tablet)
UP TO 6 YEARS
No adjusted dosage is yet possible.
ELDERLY PATIENTS
Adjustment of the dose is recommended in elderly patients with moderate to severe renal impairment.
DURATION OF USE
The duration of use depends on the type, duration and course of the complaints. For hay fever 3-6 weeks, and in case of short-term pollen exposure as little as one week, is generally sufficient. For chronic urticaria and chronic allergic rhinitis, up to one year’s clinical experience is available for the racemate and up to 18 months in patients with pruritus associated with atopic dermatitis.